Media & Announcements
Polpharma Group at CPHI Milan 2026: Strengthening Partnerships Across the Global Pharmaceutical Value Chain
At CPHI Milan 2026, a Polpharma delegation led by CEO Sebastian Szymanek met partners on APIs, finished dosage forms, CDMO services and new technologies.
Group News
October 21, 2026
Polpharma at EFNI 2026: Building Innovation, Resilience and Europe’s Future
At EFNI 2026 in Sopot, Polpharma shared its innovation experience and joined debates on resilient supply chains and Europe’s industrial future.
Group News
October 21, 2026
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
Polpharma Group’s R&D supports growth in key therapeutic areas.
Polpharma Group's research and development capabilities support growth across its key therapeutic areas and strengthen its product pipeline.
Group News
June 26, 2026
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
.avif)
.avif)
The Leonardo Innovation Program won the Gold Stevie Awards® gold statuette in the 19th edition of the prestigious international competition International Business Awards®!
The Leonardo employee innovation programme wins Gold at the Stevie International Business Awards for creativity, engagement and innovative communication.
Group News
August 16, 2022
Polpharma API completed step 1. Risk Evaluation according to EMA’s request concerning presence of nitrosamines in drug products.
Polpharma completed EMA risk assessment for nitrosamines in chemically synthesised APIs, identifying optimisation parameters for highest quality.
Group News
December 17, 2020
Press releases
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Tender Notices
No items found.
December 1, 2023
Ampoules visual inspection and leak detection line for sale
Polfa Warszawa invites tenders to buy a decommissioned ampoule visual inspection and leak detection line (Eisai, ZMR and Brevetti devices).
Tender Notices
No items found.
November 21, 2023
Aseptic glass vials filling line for sale
Polfa Warszawa invites tenders to buy a decommissioned 2008 Bosch aseptic filling line for glass vials, including washer, tunnel and capper.
Science & Innovation
Polpharma API
October 15, 2023
Polpharma’s new kilo-scale development and production laboratory is up and running
Polpharma, Poland's largest API maker, launches a new kilo-scale development and production laboratory for the most advanced active substances.
Group News
Polpharma API
October 11, 2023
KiloLab Laboratory: strategic milestone achieved!
Polpharma launches KiloLab Laboratory for kilogram-scale development under GMP, featuring isolators and reactors for high-potency API production.
Tender Notices
No items found.
October 4, 2023
Tenders for the purchase of decommissioned assets from technical Infrastcture area, including used: technical devices, installations and systems, measuring equipment, air compressors, chillers and laundry equipment – Infrastructure 2
Polfa Warszawa invites tenders to buy decommissioned technical infrastructure: devices, systems, measuring equipment, compressors and chillers.
Latest stories
featured
.avif)
For the media
Media Kit
Logos, photography and the Group boilerplate.
ZIP file (112.28 kb) updated quarterly
Group factsheet
Revenue, footprint, pipeline, employment and history.
Pdf file (112.28 kb) updated quarterly
Press Contact
Logos, photography and the Group boilerplate.
press@polpharma.com
RESPONDS WITHIN ONE BUSINESS DAY